Clinuvel Pharmaceuticals Limited DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) — Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE® (afamelanotide) and the future of photomedicine. Over 70 guests discussed the Company’s unique history and future growth potential at an invitation-only event in Düsseldorf. Managing Director and CEO, Dr